GrantExec

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

This funding opportunity supports research into how certain diabetes medications may influence cancer risk, encouraging studies that explore the underlying biological mechanisms involved.

Contact for amount
Closed
Nationwide
Key Dates

Application Opens

August 23, 2023

Application Closes

November 17, 2024

Contact Information

Grantor

NIH Grants Information

Subscribe to view contact details

Newsletter Required
Categories
Education
Health